Source disclosure: January 30, 2026
Medical Data Vision Co., Ltd. [3902.T]
TOKYO, Jan 30 (Kyodo) - Medical Data Vision Co., Ltd. (Code No.: 3902, Prime Market), announced today that its board of directors has resolved to set the record date for convening an extraordinary shareholders' meeting scheduled for late March 2026.
The company's president and CEO, Hiroshi Iwasaki, stated that the decision was made to ensure clarity on who will be eligible to exercise voting rights at the upcoming meeting. The record date, which determines shareholder eligibility, is set for February 16, 2026. This means that only those listed as shareholders on the final register of shareholders on this day will have the right to vote at the extraordinary meeting. An announcement regarding this record date will be published on February 2, 2026, via electronic bulletin on the company’s official website at https://www.mdv.co.jp/ir/stock/fr_public.html.
Additionally, the company highlighted key proposals expected to be discussed during the extraordinary meeting. These include the potential merger of shares under Article 180 of Japan's Companies Act if Nippon Life Insurance Company fails to acquire all outstanding common shares through its tender offer, excluding shares held by SBI Holdings Corporation and treasury shares owned by the company itself. Furthermore, the proposal includes amending the articles of incorporation to abolish the stipulated number of shares per unit contingent upon the effectiveness of such share merger.
Medical Data Vision also noted that it would prepare for the possibility of holding the extraordinary meeting by setting the record date in advance. However, should the tender offer not succeed, the company intends not to convene the extraordinary meeting nor utilize the designated record date. Further details about the exact timing, location, and specifics of the agenda items will be communicated once finalized.
AI-translated content. 🟢 Confidence: High See terms • Original filing